Filing Details
- Accession Number:
- 0000950170-23-072291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-21 17:00:47
- Reporting Period:
- 2023-12-18
- Accepted Time:
- 2023-12-21 17:00:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1783328 | Tscan Therapeutics Inc. | TCRX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1120355 | J Timothy Barberich | C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Voting Common Stock | Acquisiton | 2023-12-18 | 28,830 | $4.89 | 66,710 | No | 4 | P | Direct | |
Voting Common Stock | Acquisiton | 2023-12-19 | 317 | $4.97 | 67,027 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Voting Common Stock | 33,259 | Indirect | By Barberich Family Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.63 to $5.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.